EUVIMEDEUVIMED entdecken
Crossref

SMC1A epilepsy syndrome: clinical data from a large international cohort

Elisabetta Gibellato, Paola Cianci iD, Milena Mariani, Barbara Parma, Sylvia Huisman, Robert Śmigiel, Anne-Marie Bisgaard, Valentina Massa iD, Cristina Gervasini iD, Alex Moretti iD, Alessandro Cattoni, Andrea Biondi und 1 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Elisabetta Gibellato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, "Mariani" Center for Fragile Child, ASST Lariana, Sant'Anna Hospital, Como, Italy. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Chromosomal Proteins, Non-Histone, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: SMC1A Foundation, Mariani Foundation, S.I.L.V.I.A. Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SMC1A epilepsy syndrome or developmental and epileptic encephalopathy‐85 with or without midline brain defects (DEE85, OMIM #301044) is an X‐linked neurologic disorder associated with mutations of the SMC1A gene, which is also responsible for about 5% of patients affected by Cornelia de Lange syndrome spectrum (CdLS). Only described in female patients, SMC1A epilepsy syndrome is characterized by the onset of severe refractory epileptic seizures in the first year of life, global developmental delay, a variable degree of intellectual disability, and dysmorphic facial features not typical of CdLS. This was a descriptive observational study for the largest international cohort with this specific disorder. The main goal of this study was to improve the knowledge of the natural history of this phenotype with particular attention to the psychomotor development and the epilepsy data. The analyzed cohort shows normal prenatal growth with the subsequent development of postnatal microcephaly. The incidence of neonatal problems (seizures and respiratory compromise) is considerable (51.4%). There is a significant prevalence of central nervous system (20%) and cardiovascular malformations (20%). Motor skills are generally delayed. The presence of drug‐resistant epilepsy is confirmed; the therapeutic role of a ketogenic diet is still uncertain. The significant regression of previously acquired skills following the onset of seizures has been observed. Facial dysmorphisms are variable and no patient shows a classic CdLS phenotype. To sum up, SMC1A variants caused drug‐resistant epilepsy in these patients, more than two‐thirds of whom were shown to progress to developmental and epileptic encephalopathy. The SMC1A gene variants are all different from each other (apart from a couple of monozygotic twins), demonstrating the absence of a mutational hotspot in the SMC1A gene. Owing to the absence of phenotypic specificity, whole‐exome sequencing is currently the diagnostic gold standard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsChromosomal Proteins, Non-HistoneMutationHumansFemaleMaleChild, PreschoolInfantChildEpilepsyPhenotypeCohort StudiesAdolescentInfant, NewbornEpileptic SyndromesDe Lange SyndromeStructural Maintenance of Chromosome Protein 1

Stichwörter der Autor:innen

Cornelia de Lange syndrome spectrumSMC1A genecohesinopathydevelopmental disabilitydrug‐resistant epilepsy

Substanzen

Structural Maintenance of Chromosome Protein 1Cell Cycle ProteinsChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Pediatric Department, "Mariani" Center for Fragile Child, ASST Lariana, Sant'Anna Hospital, Como, Italy.
  • Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Pediatric Department, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Pediatric Department, Endocrinology, Diabetology and Metabolic Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Pediatric Department and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Department of Health Sciences, University of Milan, Milan, Italy.

ORCID-Profile: Paola Cianci, Valentina Massa, Cristina Gervasini, Alex Moretti, Angelo Selicorni

Förderung

  • SMC1A Foundation
  • Mariani Foundation
  • S.I.L.V.I.A. Association
  • Fondazione Pierfranco e Luisa Mariani

Zitieren

APA

Gibellato, E., Cianci, P., Mariani, M., Parma, B., Huisman, S., Śmigiel, R., Bisgaard, A. M., Massa, V., Gervasini, C., Moretti, A., Cattoni, A., Biondi, A., & Selicorni, A. (2024). SMC1A epilepsy syndrome: clinical data from a large international cohort. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63577

Vancouver

Gibellato E, Cianci P, Mariani M, Parma B, Huisman S, Śmigiel R, et al. SMC1A epilepsy syndrome: clinical data from a large international cohort. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63577

BibTeX
@article{Gibellato2024,
  author = {Gibellato, Elisabetta and Cianci, Paola and Mariani, Milena and Parma, Barbara and Huisman, Sylvia and Śmigiel, Robert and Bisgaard, Anne-Marie and Massa, Valentina and Gervasini, Cristina and Moretti, Alex and Cattoni, Alessandro and Biondi, Andrea and Selicorni, Angelo},
  title = {SMC1A epilepsy syndrome: clinical data from a large international cohort},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63577}
}
Kostenlos starten →